Skip to content

Combined Illness Management and Psychotherapy in Treating Depressed Elders

Combined Illness Management and Psychotherapy in Treating Depressed Elders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01337726
Acronym
COPE
Enrollment
226
Registered
2011-04-19
Start date
2011-02-28
Completion date
2016-10-31
Last updated
2017-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Depression, Heart Failure

Keywords

Depression, Heart Failure, Chronic Obstructive Pulmonary Disease, Quality of Life, Functional Impairment

Brief summary

The purpose of this research study is to test a program developed to help patients with chronic heart or lung problems take care of themselves and cope with their illness or limitations.

Interventions

BEHAVIORALCombined Psychotherapy and Illness Management

Participants will have 10 weekly visits with a study clinician at their home and by phone. They will focus on their self care and illness management as well as how to manage their mood/cope emotionally. Follow up assessments will occur at 26 and 52 weeks.

BEHAVIORALIllness Management Only

Participants in this group will have 10 weekly sessions with a study clinician at home and by phone. They will focus only on how they manage their illness. Follow up assessments will occur at 26 and 52 weeks.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Iowa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 55 years or older * Diagnosis of Heart Failure or COPD * Depressive symptoms indicated by a BDI-II score of 10 or higher * Functional impairment

Exclusion criteria

* Current psychotherapy * Cognitive Impairment * Psychiatric diagnosis * Active suicidal thoughts * Significant vision or hearing impairment * Residence in long term care facility

Design outcomes

Primary

MeasureTime frameDescription
Reduction in depressive symptoms10 weeksChange from Baseline in depressive symtoms at 10 weeks

Secondary

MeasureTime frameDescription
Improvement in quality of life/functioning10 weeksChange from Baseline in quality of life/functioning at 10 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026